Real-world antithrombotic strategies in patients with atrial fibrillation and recently developed acute coronary syndrome
The present findings suggest the appropriate optimization of antithrombotic medication balancing in patients with AF and ACS in Japan by reducing the intensity of antiplatelets during the study period.
Authors
- Hiroshi Iwata (ORCID: https://orcid.org/0000-0001-7098-9406)
- Hiroyuki Daida
- Shuko Nojiri (ORCID: https://orcid.org/0000-0003-0422-8152)
- Yuichi Chikata (ORCID: https://orcid.org/0000-0001-8550-4125)
- Yuji Nishizaki (ORCID: https://orcid.org/0000-0002-6964-6702)
- Katsumi Miyauchi
Institutions
- Juntendo University (JP)
Publication Details
- Journal
- International Journal of Cardiology Cardiovascular Risk and Prevention
- Published
- 2024-10-08
- DOI
- https://doi.org/10.1016/j.ijcrp.2024.200339
- Citations
- 2
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- Bristol-Myers Squibb
- Pfizer
- Pfizer Japan